SOURCE: Grupo International (HIV-VAC, Inc.)

February 01, 2011 09:15 ET

Grupo International Inc. Extends $4,500,000 Acquisition Sixty Days

LAS VEGAS, NV--(Marketwire - February 1, 2011) - Grupo International, Inc. (PINKSHEETS: GRPI) has extended for sixty days, the proposed acquisition of 80% of Richard Y Lange S. A. De C.V. while it completes its due diligence process. Under the agreement, shareholders of Richard Y Lange have agreed to exchange 80% of the share capital of Richard Y Lange for 8,000,000 common shares of Grupo International Inc. These assets, with a book value of $4.5 Million, are comprised mainly of Real Estate and operating businesses throughout Baja, California. The businesses include the RiMart Specialty Tool and Franchised Hardware Stores, Mining Sand Concessions, a Cement Block Manufacturing Plant, Construction, and an in house Preferred Credit Card Division. Each operation acts as a vertical integration allowing for a competitive working structure.

RiMart is servicing and supplying inventory to 20 stores up from 10 stores of just 6 months ago. The Company has been combining these operations over the last few months. Richard Y Lange now employs over 100 people. Grupo International plans to expand these new core businesses throughout Mexico, United States, and South America. The acquisition of Richard Y Lange is expected to add additional growth for Grupo International for many years. The Company's plans for its Medical Division will be announced in the next quarter.

The Company has recently changed its name from "Hiv-Vac Inc." to "Grupo International, Inc." and trades under the new symbol of "GRPI" to better reflect its business model. Additional information can be found in the Company's most recent 8k filing and the Company's web site ( describing the business and transaction.

For additional information please contact Investors Relations listed below:

Safe Harbor:

The information contained in this press release, including any "forward-looking" statements within the meaning of section 27A of the securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 contained herein, should be reviewed in conjunction with the Company's Annual Report on Form 10-KSB and other publicly available information regarding the Company, copies of which are available from the Company upon request. Such publicly available information sets forth many risks and uncertainties related to the Company's business and such statements, including risks and uncertainties related to that are unpredictable and outside of the influence and/or control of the Company. In particular, these risks and uncertainties include, without limitation: that third parties may be successful in challenging the patent issued; that granted claims may be held invalid or interpreted differently by a court of law; that other patents will issue that will block the Company from commercializing the technology covered by the patents; and that the benefits that Company believes can be derived from the patented technology will not be realized due to difficulties encountered in the long and expensive process of the development of new technologies and the cost and uncertainty in obtaining regulatory approval for products based on these technologies. In addition, there are many other risks and uncertainties inherent in the development of the Company's products, including the risk of not obtaining regulatory approval for a variety of reasons and the risk of adverse side effects in humans. Other risks relating to Company are detailed from time to time in documents filed by Company with the SEC.

Contact Information

    Grupo International Inc.
    Investors Relations: